These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20151726)

  • 1. Cost effectiveness of high-dose intravenous esomeprazole for peptic ulcer bleeding.
    Barkun AN; Adam V; Sung JJ; Kuipers EJ; Mössner J; Jensen D; Stuart R; Lau JY; Nauclér E; Kilhamn J; Granstedt H; Liljas B; Lind T
    Pharmacoeconomics; 2010; 28(3):217-30. PubMed ID: 20151726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous esomeprazole: a pharmacoeconomic profile of its use in the prevention of recurrent peptic ulcer bleeding.
    Keating GM
    Pharmacoeconomics; 2011 Jun; 29(6):535-43. PubMed ID: 21568358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost-effectiveness analysis.
    Barkun AN; Herba K; Adam V; Kennedy W; Fallone CA; Bardou M
    Aliment Pharmacol Ther; 2004 Mar; 19(5):591-600. PubMed ID: 14987328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and tolerability of high-dose intravenous esomeprazole for prevention of peptic ulcer rebleeding.
    Kuipers EJ; Sung JJ; Barkun A; Mössner J; Jensen D; Stuart R; Lau JY; Ahlbom H; Lind T; Kilhamn J
    Adv Ther; 2011 Feb; 28(2):150-9. PubMed ID: 21181319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous esomeprazole infusion versus bolus administration and second look endoscopy for the prevention of rebleeding in children with a peptic ulcer.
    Belei O; Olariu L; Puiu M; Jinca C; Dehelean C; Marcovici T; Marginean O
    Rev Esp Enferm Dig; 2018 Jun; 110(6):352-357. PubMed ID: 29465250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous Esomeprazole for Prevention of Peptic Ulcer Rebleeding: A Randomized Trial in Chinese Patients.
    Bai Y; Chen DF; Wang RQ; Chen YX; Shi RH; Tian DA; Chen H; Eklund S; Li ZS;
    Adv Ther; 2015 Nov; 32(11):1160-76. PubMed ID: 26581750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial.
    Sung JJ; Barkun A; Kuipers EJ; Mössner J; Jensen DM; Stuart R; Lau JY; Ahlbom H; Kilhamn J; Lind T;
    Ann Intern Med; 2009 Apr; 150(7):455-64. PubMed ID: 19221370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage.
    Spiegel BM; Dulai GS; Lim BS; Mann N; Kanwal F; Gralnek IM
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):988-997. PubMed ID: 16844422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost implications of administering intravenous proton pump inhibitors to all patients presenting to the emergency department with peptic ulcer bleeding.
    Gagnon YM; Levy AR; Eloubeidi MA; Arguedas MR; Rioux KP; Enns RA
    Value Health; 2003; 6(4):457-65. PubMed ID: 12859587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessment of Rebleeding Risk of Forrest IB (Oozing) Peptic Ulcer Bleeding in a Large International Randomized Trial.
    Jensen DM; Eklund S; Persson T; Ahlbom H; Stuart R; Barkun AN; Kuipers EJ; Mössner J; Lau JY; Sung JJ; Kilhamn J; Lind T
    Am J Gastroenterol; 2017 Mar; 112(3):441-446. PubMed ID: 28094314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double oral esomeprazole after a 3-day intravenous esomeprazole infusion reduces recurrent peptic ulcer bleeding in high-risk patients: a randomised controlled study.
    Cheng HC; Wu CT; Chang WL; Cheng WC; Chen WY; Sheu BS
    Gut; 2014 Dec; 63(12):1864-72. PubMed ID: 24658598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of high-dose intravenous esomeprazole in patients with peptic ulcer bleeding in the USA and Europe.
    Brown RE; Nandi J
    Expert Rev Pharmacoecon Outcomes Res; 2010 Aug; 10(4):371-4. PubMed ID: 20715913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intravenous and oral esomeprazole in the prevention of recurrent bleeding from peptic ulcers after endoscopic therapy.
    Sung JJ; Suen BY; Wu JC; Lau JY; Ching JY; Lee VW; Chiu PW; Tsoi KK; Chan FK
    Am J Gastroenterol; 2014 Jul; 109(7):1005-10. PubMed ID: 24777150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of high-dose oral proton pump inhibition after endoscopy in the acute treatment of peptic ulcer bleeding.
    Barkun AN; Herba K; Adam V; Kennedy W; Fallone CA; Bardou M
    Aliment Pharmacol Ther; 2004 Jul; 20(2):195-202. PubMed ID: 15233700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy.
    Yen HH; Yang CW; Su WW; Soon MS; Wu SS; Lin HJ
    BMC Gastroenterol; 2012 Jun; 12():66. PubMed ID: 22681960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Vonoprazan Versus Intravenous Proton Pump Inhibitor for Prevention of High-Risk Peptic Ulcers Rebleeding After Successful Endoscopic Hemostasis: A Multicenter Randomized Noninferiority Trial.
    Geeratragool T; Kaosombatwattana U; Boonchote A; Chatthammanat S; Preechakawin N; Srichot J; Sudcharoen A; Sirisunhirun P; Termsinsuk P; Rugivarodom M; Limsrivilai J; Maneerattanaporn M; Pausawasdi N; Leelakusolvong S
    Gastroenterology; 2024 Sep; 167(4):778-787.e3. PubMed ID: 38582271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous esomeprazole for prevention of peptic ulcer re-bleeding: rationale/design of Peptic Ulcer Bleed study.
    Sung JJ; Mössner J; Barkun A; Kuipers EJ; Lau J; Jensen D; Stuart R; Junghard O; Olsson G;
    Aliment Pharmacol Ther; 2008 Apr; 27(8):666-77. PubMed ID: 18248654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the best strategy for diagnosis and treatment of Helicobacter pylori in the prevention of recurrent peptic ulcer bleeding? A cost-effectiveness analysis.
    Gené E; Sanchez-Delgado J; Calvet X; Gisbert JP; Azagra R
    Value Health; 2009; 12(5):759-62. PubMed ID: 19490560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial of standard versus high-dose intravenous omeprazole after endoscopic therapy in high-risk patients with acute peptic ulcer bleeding.
    Chan WH; Khin LW; Chung YF; Goh YC; Ong HS; Wong WK
    Br J Surg; 2011 May; 98(5):640-4. PubMed ID: 21305536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.